On February 6, JPMorgan purchased an additional 585,900 shares of Innovent Bio (01801) at HK$79.232 per share, amounting to approximately HK$46.422 million. Following this transaction, the financial institution's total holding in the company reached around 87.2176 million shares, representing a stake of 5.02%.